APA (7th ed.) Citation

Damhofer, H., Tatar, T., Southgate, B., Scarneo, S., Agger, K., Shlyueva, D., . . . Helin, K. (2024, April). TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers. Cell Death and Disease.

Chicago Style (17th ed.) Citation

Damhofer, Helene, et al. "TAK1 Inhibition Leads to RIPK1-dependent Apoptosis in Immune-activated Cancers." Cell Death and Disease Apr. 2024.

MLA (9th ed.) Citation

Damhofer, Helene, et al. "TAK1 Inhibition Leads to RIPK1-dependent Apoptosis in Immune-activated Cancers." Cell Death and Disease, Apr. 2024.